Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2023 16:15 ET | Source: MRC Global

MRC Global Announces Second Quarter 2023 Results

HOUSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC), the leading global distributor of pipe, valves, fittings and infrastructure products and services to diversified energy,...
May 08, 2023 16:15 ET | Source: MRC Global

MRC Global Announces First Quarter 2023 Results

HOUSTON, May 08, 2023 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC), the leading global distributor of pipe, valves, fittings and infrastructure products and services to diversified energy,...
February 13, 2023 16:15 ET | Source: MRC Global

MRC Global Reports Full Year and Fourth Quarter 2022 Results and 2023 Outlook

HOUSTON, Feb. 13, 2023 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE: MRC), the leading global distributor of pipe, valves and fittings (PVF) and other infrastructure products and services to...
February 10, 2023 05:00 ET | Source: Magna International Inc.

Magna Announces Fourth Quarter 2022 Results and 2023 Outlook

Fourth Quarter 2022 Highlights Sales increased 5% to $9.6 billionExcluding foreign currency translation sales increased 13%, compared to a global light vehicle production increase of 5%Diluted...
January 10, 2023 16:58 ET | Source: Magna International Inc.

Magna Announces Date for Q4 & Year End 2022 Results and 2023 Outlook Conference Call

AURORA, Ontario, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX:MG) (NYSE:MGA) MAGNA ANNOUNCES DATE FOR Q4 & YEAR END 2022 RESULTS and 2023 OUTLOOK CONFERENCE CALL FRIDAY –...
January 09, 2023 07:00 ET | Source: Travere Therapeutics, Inc.

Travere Therapeutics Provides Corporate Update and 2023 Outlook

Company well-positioned for potential FDA Subpart H approval and commercial launch of sparsentan for IgA nephropathy (IgAN) in 1Q23, followed by potential EMA approval in second half of 2023 ...
December 19, 2022 02:30 ET | Source: Virbac

VIRBAC : Perspectives 2023

Alors que nous poursuivons l'exécution de notre plan stratégique 2030, nous avons pris la décision de continuer d'accélérer en 2023 sur deux dimensions clés : la R&D et les investissements. Afin...
December 19, 2022 02:30 ET | Source: Virbac

VIRBAC : 2023 Outlook

As we continue to execute our 2030 strategic plan, we have made the decision to continue to accelerate in 2023 on two key dimensions : R&D and capital expenditures. In order to maximize the...